Evidence map›Paper›PMID 32299805›Full record

ArticleeNeuro

Impaired Motor Recycling during Action Selection in Parkinson's Disease.

Matthias Fritsche, Robrecht P R D van der Wel, Robin Smit, Bastiaan R Bloem, Ivan Toni, Rick C Helmich

Abstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthias FritscheCentre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6525 EN, The Netherlands m.fritsche@donders.ru.nl.ORCID 0000-0001-5835-9057
Robrecht P R D van der WelDepartment of Psychology, Rutgers University, Camden, NJ 08102.ORCID 0000-0003-3552-2557
Robin SmitDonders Institute for Brain, Cognition and Behaviour; Department of Neurology; Center of Expertise for Parkinson & Movement Disorders, Radboud University Medical Center, Nijmegen 6525 GC, The Netherlands.
Bastiaan R BloemDonders Institute for Brain, Cognition and Behaviour; Department of Neurology; Center of Expertise for Parkinson & Movement Disorders, Radboud University Medical Center, Nijmegen 6525 GC, The Netherlands.ORCID 0000-0002-6371-3337
Ivan ToniCentre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6525 EN, The Netherlands.ORCID 0000-0003-0936-3601
Rick C HelmichCentre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6525 EN, The Netherlands.ORCID 0000-0003-4035-6573

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Behavioral studies have shown that the human motor system recycles motor parameters of previous actions, such as movement amplitude, when programming new actions. Shifting motor plans toward a new action forms a particularly severe problem for patients with Parkinson's disease (PD), a disorder that, in its early stage, is dominated by basal ganglia dysfunction. Here, we test whether this action selection deficit in Parkinson's patients arises from an impaired ability to recycle motor parameters shared across subsequent actions. Parkinson's patients off dopaminergic medication (

Indexed as

Parkinson DiseaseBasal GangliaDopamine AgentsHandHumansMovementDopamine Agentsbasal gangliamotor efficiencymotor planningParkinson’s diseasepriming

Identifiers

PMID32299805
PMCPMC7218010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.